Clinical Trials in Georgia

Showing 15061-15080 of 19,050 trials

Post-approval Study of The Glaukos® iStent® Trabecular Micro-bypass Stent: Extended Follow-up of the Premarket Cohort

NCT01836042

The purpose of this study is to assess the long-term safety of the Glaukos® iStent® Trabecular Micro-Bypass Stent Model GTS100R/L in subjects previously enrolled in Glaukos Study GC-003.

Primary Open Angle Glaucoma

Glaukos Corporation108 participantsStarted Jul 2013

Beverly Hills, California, United States • Petaluma, California, United States • Sacramento, California, United States +23 more locations

COMPLETEDPhase 363 miles

IFN-free Combination Therapy in HCV-infected Patients Treatment-naive:HCVerso1

NCT01732796

The aim of the study is to confirm efficacy of treatment for 16 and 24 weeks in chronically infected HCV GT1b treatment naïve patients, including patients with compensated cirrhosis.

Hepatitis C, Chronic

Boehringer Ingelheim470 participantsStarted Dec 2012

Dothan, Alabama, United States • Chula Vista, California, United States • La Mesa, California, United States +98 more locations

Post-approval Study of The Glaukos® iStent® Trabecular Micro-bypass Stent: Extended Follow-up of the Premarket Cohort

IFN-free Combination Therapy in HCV-infected Patients Treatment-naive:HCVerso1

Find Trials by Condition in Georgia

Point-Of-Care TBI Detection System For Head Injured Patients In The Emergency Department

Persistence of Antibodies in Adolescents and Adults 15 to 23 Years Who Received One Dose of Menactra® or Menomune®

Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast Cancer

A Study of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) as Second-line Therapy for Patients With KRAS Positive or Squamous Cell Non-Small Cell Lung Cancer

Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Children (3 to < 9 Years)

Persistence of Bactericidal Antibodies in Adolescents and Adults Who Had Received a Single Dose of Menactra® Vaccine

A Phase II Evaluation of Dasatinib (Sprycel®, NSC #732517) in the Treatment of Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma

A Study of Multiple Doses of AbGn-168H by Intravenous Infusion in Patients With Moderate to Severe Chronic Plaque Psoriasis

Study of Influenza Vaccine Revaccination in Healthy Adults Previously Vaccinated With Fluzone ID or Fluzone IM

Capecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal Cancer

Dose Comparison Study of Menactra® in US Children

Fat Reduction in the Flanks Area vs. Control

Immunogenicity of High-dose Inactivated, Split-virion Influenza Vaccine Versus Standard Fluzone Vaccine in the Elderly

Microbiology Testing With the Aim Of Directed Antimicrobial Therapy For CAP

AMG 595 First-in-Human in Recurrent Gliomas

A Safety Study for Cethrin (BA-210) in the Treatment of Acute Thoracic and Cervical Spinal Cord Injuries

Brief Cognitive Behavioral Therapy (CBT) for Pediatric Anxiety and Depression in Primary Care

G5® Mobile Continuous Glucose Monitoring System Automated vs. Manual Sensor Applicator